TMDX - TransMedics Group Inc

TMDX - TransMedics Group Inc

https://www.transmedics.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

Why TransMedics ( TMDX ) is a Top Growth Stock for the Long-Term

Zacks Commentary • 6 days, 18 hours ago • score: 0.34

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Reasons to Retain TransMedics Stock in Your Portfolio for Now

Zacks Commentary • 2 weeks, 2 days ago • score: 0.46

TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.

$100 Invested In TransMedics Group 5 Years Ago Would Be Worth This Much Today - TransMedics Group ( NASDAQ:TMDX )

Benzinga • 2 weeks, 3 days ago • score: 0.39

TransMedics Group TMDX has outperformed the market over the past 5 years by 32.45% on an annualized basis producing an average annual return of 45.27%. Currently, TransMedics Group has a market capitalization of $4.00 billion.

Why Is TransMedics ( TMDX ) Down 1.9% Since Last Earnings Report?

Zacks Commentary • 2 weeks, 3 days ago • score: 0.21

TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why TransMedics ( TMDX ) is a Strong Momentum Stock

Zacks Commentary • 3 weeks, 3 days ago • score: 0.13

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why TransMedics ( TMDX ) is a Strong Growth Stock

Zacks Commentary • 3 weeks, 5 days ago • score: 0.37

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

TransMedics ( TMDX ) Recently Broke Out Above the 50-Day Moving Average

Zacks Commentary • 1 month ago • score: 0.56

When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.

52W High

$169.29

52W Low

$55.00

MA Status:

50D: Below 200D: Above

Beta (~1 neutral, <0.9 lower risk)

2.17

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

52.27

Forward P/E (<15 better)

46.95

EV/EBITDA (<8 favorable)

32.73

EV/Revenue (<3 favorable)

6.90

P/S (TTM) (<3 favorable)

6.67

P/B (<3 favorable)

11.15

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

3.01%

Institutions (25–75% balanced)

111.48%

Shares Outstanding

34,090,400

Float

32,955,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

531,292,000

Gross Profit (TTM)

317,675,000

EPS (TTM)

1.99

Profit Margin (>10% good)

0.14%

Operating Margin (TTM) (higher better)

0.23%

ROE (TTM) (>15% strong)

0.28%

EPS YoY (Quarterly) (>10% good)

1.63

Revenue YoY (Quarterly) (>8% good)

0.38

Momentum

Bearish momentum

Value

-2.8231

Previous

-3.4663

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025